Akouos, Inc. announced the appointment of Aaron Tward, M.D., Ph.D., as chief scientific officer. Dr. Tward is a surgeon and a scientist with deep experience in genetics, genomics, gene delivery, high-throughput sequencing technologies, and the clinical care of patients with conditions of the ear and skull base. Dr. Tward was previously a member of the Akouos scientific advisory board since 2018.

As chief scientific officer, he will lead the research team, and provide strategic scientific expertise to advance the company's precision genetic medicine platform to address a broad range of inner ear conditions. Dr. Tward joins Akouos with robust expertise in otology, neurotology, and skull base surgery focused clinical applications and research. He has served as an associate professor of Otolaryngology – Head and Neck Surgery at the University of California, San Francisco (UCSF).